Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes.

Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes.

OBJECTIVE: Diacerein has proved to be effective in the treatment of osteoarthritis (OA). However, the precise action mechanism of diacerein on OA is not yet fully understood. Therefore, we investigated the effects of rhein, an active metabolite of diacerein, on the production of promatrix metallopro...

Full description

Bibliographic Details
Main Authors:	Tamura, T, Kosaka, N, Ishiwa, J, Sato, T, Nagase, H, Ito, A
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Naringenin regulates production of matrix metalloproteinases in the knee-joint and primary cultured articular chondrocytes and alleviates pain in rat osteoarthritis model
by: C.C. Wang, et al.

The effect of food intake on the pk of rhein released from diacerein
by: Ming Huang, et al.
Published: (2020-04-01)

Rosmarinic acid induces rabbit articular chondrocyte differentiation by decreases matrix metalloproteinase-13 and inflammation by upregulating cyclooxygenase-2 expression
by: Seong-Hui Eo, et al.
Published: (2017-09-01)

The Effects of the Combination of Rhein and Platelet-Rich Plasma on Human Articular Chondrocytes
by: Mario Simental-Mendía, et al.
Published: (2023-08-01)

Inhibition of metalloproteinases in articular cartilage
by: Stinn, Jennifer L. (Jennifer Leigh)
Published: (2007)

Ekspresi Gen Tissue Inhibitor Metalloproteinase-1 Pada Sel Sinoviosit Osteoartritis Grade IV Setelah Pemberian Diacerein
by: Vivi Sofia, et al.
Published: (2018-03-01)

Zymography of metalloproteinases.
by: Troeberg, L, et al.
Published: (2004)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
by: Visse, R, et al.
Published: (2003)

Degradation of interleukin 1beta by matrix metalloproteinases.
by: Ito, A, et al.
Published: (1996)

Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer
by: Md. Towhedul Islam, et al.
Published: (2024-04-01)

Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
by: Nagase, H, et al.
Published: (2003)

Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
by: Wei, S, et al.
Published: (2003)

Matrix metalloproteinases in cancer.
by: Itoh, Y, et al.
Published: (2002)

Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
by: Itoh, Y, et al.
Published: (1995)

Regulation of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Abdominal Aortic Aneurysm
by: Shuo Wang, et al.
Published: (2023-09-01)

Structural requirements for collagenolytic activity of matrix metalloproteinase 1 (MMP-1)
by: Chung, L, et al.
Published: (2000)

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) - Physiological roles and structural basis of MMP inhibition by TIMP-1
by: Nagase, H, et al.
Published: (2000)

Progress in matrix metalloproteinase research.
by: Murphy, G, et al.
Published: (2008)

Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, Interleukin-1β and TNF-α
by: Masahiro Sasaki, et al.
Published: (2000-01-01)

A personal journey with matrix metalloproteinases
by: Nagase, H
Published: (2016)

Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
by: Minond, D, et al.
Published: (2004)

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
by: Ogata, Y, et al.
Published: (1995)

Membrane-type matrix metalloproteinases: Their functions and regulations
by: Itoh, Y
Published: (2015)

The metalloproteinase PAPP-A is required for IGF-dependent chondrocyte differentiation and organization
by: Mette Harboe, et al.
Published: (2024-08-01)

Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
by: Cui, Y, et al.
Published: (2010)

The Chondroprotective Agent ITZ-1 Inhibits Interleukin-1β–Induced Matrix Metalloproteinase–13 Production and Suppresses Nitric Oxide– Induced Chondrocyte Death
by: Haruhide Kimura, et al.
Published: (2009-01-01)

Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
by: Ogata, Y, et al.
Published: (2001)

Combined Effect of Subchondral Drilling and Hyaluronic Acid with/without Diacerein in Full-Thickness Articular Cartilage Lesion in Rabbits
by: Wanwisa Suwannaloet, et al.
Published: (2012-01-01)

Structure and function of matrix metalloproteinases and TIMPs.
by: Nagase, H, et al.
Published: (2006)

Epigenetic Regulation of Matrix Metalloproteinase-1 and -3 Expression in Mycobacterium tuberculosis Infection
by: Rachel C. Moores, et al.
Published: (2017-05-01)

Homophilic complex formation of MT1-matrix metalloproteinase is essential to express collagenolytic activity on the cell surface
by: Itoh, Y, et al.
Published: (2005)

Salinomycin causes dedifferentiation via the extracellular signal-regulated kinase (ERK) pathway in rabbit articular chondrocytes
by: Seon-Mi Yu, et al.
Published: (2015-02-01)

Localizing matrix metalloproteinase activities in the pericellular environment.
by: Murphy, G, et al.
Published: (2011)

Metalloproteinases in health and disease: challenges and the future prospects.
by: Nagase, H, et al.
Published: (2011)

The FoxP1 gene regulates lung function, production of matrix metalloproteinases and inflammatory mediators, and viability of lung epithelia
by: Alexis Andreas, et al.
Published: (2022-10-01)

The role of matrix metalloproteinase-9 and the tissue inhibitor of metalloproteinase — 1 in endogenous uveitis in children
by: M. A. Khrabrova, et al.
Published: (2024-03-01)

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
by: Tita Husnitawati Madjid, et al.
Published: (2020-06-01)

Changes in Serum Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Essential Hypertension
by: Krasimir Kostov, et al.
Published: (2022-03-01)

Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
by: Daljit Kaur, et al.
Published: (2019-04-01)

Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
by: Itoh, Y, et al.
Published: (1998)